ask="3.00"
ask_size="5000"
average_daily_volume="508273"
bid="2.87"
bid_size="5200"
book_value="3.56"
change="-0.06"
change_from_200_day_moving_average="-1.63"
change_from_50_day_moving_average="0.36"
change_from_52_week_high="-6.45"
change_From_52_week_low="0.90"
change_in_percent="-2.03%"
close="2.90"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.08"
ebitda="-31.76M"
eps_estimate_current_year="-1.16"
eps_estimate_next_quarter="-0.28"
eps_estimate_next_year="-2.95"
ex_dividend_date="N/A"
float_shares="8386000"
high="3.04"
high_52_weeks="9.35"
last_trade_date="3/15/2017"
last_trade_price="2.90"
last_trade_size="2780"
last_trade_time="4:00pm"
low="2.82"
low_52_weeks="2.00"
market_capitalization="45.40M"
moving_average_200_day="4.53"
moving_average_50_day="2.54"
name="Nivalis Therapeutics
Inc."
notes="N/A"
one_year_target_price="16.63"
open="3.00"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-35.98%"
percent_change_from_50_day_moving_average="+14.21%"
percent_change_from_52_week_high="-68.98%"
percent_change_from_52_week_low="+45.00%"
previous_close="2.96"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="0.83"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="15656000"
short_ratio="0.84"
stock_exchange="NGM"
symbol="NVLS"
volume="646790"
weeks_range_52="2.00 - 9.35"
